- Home
- TMDX vs ETY Comparison
TMDX vs ETY Comparison
Compare TMDX & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- ETY
- Stock Information
- Founded
- TMDX 1998
- ETY 2006
- Country
- TMDX United States
- ETY United States
- Employees
- TMDX N/A
- ETY N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ETY Finance Companies
- Sector
- TMDX Health Care
- ETY Finance
- Exchange
- TMDX Nasdaq
- ETY Nasdaq
- Market Cap
- TMDX 4.8B
- ETY 2.4B
- IPO Year
- TMDX 2019
- ETY N/A
- Fundamental
- Price
- TMDX $128.97
- ETY $15.56
- Analyst Decision
- TMDX Buy
- ETY
- Analyst Count
- TMDX 10
- ETY 0
- Target Price
- TMDX $127.33
- ETY N/A
- AVG Volume (30 Days)
- TMDX 838.7K
- ETY 247.3K
- Earning Date
- TMDX 07-30-2025
- ETY 01-01-0001
- Dividend Yield
- TMDX N/A
- ETY 7.21%
- EPS Growth
- TMDX N/A
- ETY N/A
- EPS
- TMDX 1.41
- ETY N/A
- Revenue
- TMDX $488,227,000.00
- ETY N/A
- Revenue This Year
- TMDX $34.07
- ETY N/A
- Revenue Next Year
- TMDX $20.76
- ETY N/A
- P/E Ratio
- TMDX $92.35
- ETY N/A
- Revenue Growth
- TMDX 64.43
- ETY N/A
- 52 Week Low
- TMDX $55.00
- ETY $10.59
- 52 Week High
- TMDX $177.37
- ETY $13.46
- Technical
- Relative Strength Index (RSI)
- TMDX 59.35
- ETY 70.51
- Support Level
- TMDX $120.36
- ETY $14.85
- Resistance Level
- TMDX $133.49
- ETY $15.30
- Average True Range (ATR)
- TMDX 5.58
- ETY 0.14
- MACD
- TMDX -1.35
- ETY 0.01
- Stochastic Oscillator
- TMDX 60.26
- ETY 91.66
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.